Cardiologo Intervencionista, departamento de Hemodinamia hospital de cardiología UMAE 34, Monterrey NL, Mex. #UMAE34cathlab
Joined October 2013
- Tweets 889
- Following 539
- Followers 856
- Likes 943
107 Photos and videos
Pinned Tweet
22 Jun 2023
61 yo🧓, with NSTEMI, bcs of ostial DX lesion, besides chronic subexpanded stent in proximal LAD with severe 360° calcium.
Tx..
Dx => NC 3.0 POBA and DCB.
LAD => 3.5 shockwave and DCB.
What you think about DCB use in this double scenario ( 0-0-1 bif lesion NSTEMI/ISR-calcium)??
1
1
20
3,027
Dr. Eduardo Galvan retweeted
Mar 16
1
7
16
626
Dr. Eduardo Galvan retweeted
I am very pleased to share our latest publication as first author on management of coronary artery perforations in the Journal of American College of Cardiology(JACC).
Stepwise, case-based review from our UK centre.
🔗 jacc.org/doi/10.1016/j.jacca…
#JACC #cardiology #intervention
3
44
201
14,236
Dr. Eduardo Galvan retweeted
Feb 25
Mitral implantation of the Sapien M3 valve at HCU Valladolid.
One team, one direction: The patient.
Thank you to everyone who makes these milestones possible. Worth every sacrifice.
@sacyl @EdwardsLifesci @secardiologia @mariogago13 @AnestesiaHCUV
1
27
158
6,932
Feb 14
Hanging around on CRF CTO plus 2026 with friends.
@rickytiago @MauroEchavPinto @elpikos @mornei2011 Ulises Lopez, Francisco Díaz y Víctor Romero de BSCI
1
6
201
Dr. Eduardo Galvan retweeted
27 Nov 2025
🗞️ Hot off the press: #STAR trial
First randomized controlled trial comparing two different technical strategies in #CTO #PCI
jacc.org/doi/10.1016/j.jacc.…
18
36
97
21,928
Dr. Eduardo Galvan retweeted
15 Dec 2025
TAVI or TAVR? A timely #EHJVSHD viewpoint reviews the historical origins, guideline evolution, and semantic accuracy of transcatheter aortic valve therapy, arguing why TAVI best reflects the procedure performed👉🔗ow.ly/o78950XJrMZ
@EHJVSHDEiC @PanichellaG @IndolfiCiro @ESC_President @EAPCIPresident
2
37
134
10,343
Dr. Eduardo Galvan retweeted
14 Dec 2025
.@WHO published a guideline in JAMA on the use and indications of #GLP-1 therapies for the management of #obesity in adults. The guideline offers two conditional recommendations to inform clinical practice and health policy.
Read the guideline: ja.ma/3MxvT40
1
59
198
21,665
Guidelines recommend dual antiplatelet therapy after CABG for acute coronary syndrome, but whether it reduces adverse events as compared with aspirin alone is unclear. Research findings from the TACSI trial are summarized in a new Quick Take video. nej.md/499wznZ
ALT A visual representation of the TACSI trial, which assessed whether dual antiplatelet therapy after CABG for acute coronary syndrome reduces adverse events as compared with aspirin alone.
2
59
314
50,464
Dr. Eduardo Galvan retweeted
22 Nov 2025
A must-read paper in #EHJ!
Coronary revascularization: a long-term perspective.
A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs.
@escardio @ESC_Journals #CardioTwitter
academic.oup.com/eurheartj/a…
6
105
261
50,843
Dr. Eduardo Galvan retweeted
23 Oct 2025
ACTUALIZACIÓN: CONTRADICCIONES ENTRE PLANTA Y CONCESIONARIO
Adquirí una Volkswagen Tiguan 2025 R-Line el 23 de julio 2025. Confié en la marca y en su seguridad. Hoy, después de 3 ingresos a garantía y casi 3 meses sin mi vehículo, sigo sin solución. @Volkswagen_MX @Profeco
2
15
10
684
Dr. Eduardo Galvan retweeted
9 Sep 2025
Provocative study from the RENOVATE trialists and Samsung Med Cntr suggesting use of intravascular imaging may eliminate long-term diffs between CABG & PCI. Not definitive absent a powered RCT, but should be enough to mandate IVI in these pts, esp with class I guidelines. Agree?
13
66
220
28,325
Dr. Eduardo Galvan retweeted
28 Jul 2025
Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC #Aheadofprint @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @ignamatsant revespcardiol.org/es-estrate…
1
13
21
1,988
Dr. Eduardo Galvan retweeted
22 Jul 2025
📢 NEW State-of-the-Art Review
Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response.
This comprehensive review by García-García et al. outlines current evidence and clinical implications.
Read here: ow.ly/gxYH50Wtaso
@hect2701 @sjorge4 @christosbouran1
#Cardiology #Atherosclerosis #CoronaryImaging
2
68
163
17,612
13 Jun 2025
Knowledge, dinner, and friends, great night with @mmamas1973 an friends in #CITIC Mexico City. Hope you had have a safe come back home @mmamas1973
2
2
12
1,796
Dr. Eduardo Galvan retweeted
20 May 2025
New in EuroIntervention🔥
SCAI/EAPCI/ACVC expert consensus on cardiogenic shock in women.
A comprehensive, evidence-based guide to diagnosis, monitoring, and treatment—across CS etiologies and clinical settings. #europcr #eapci #cardiogenicshock
ow.ly/fAn250VVpLr
40
72
6,290
Dr. Eduardo Galvan retweeted
12 May 2025
Are pressure-based indices vessel agnostic? Pressure derived indices in the Left Main @achir76 @drkogallagher @DrOzanDemir @k_desilva @mattlkw @divaka_perera @ukHeartResearch @theBHF #cardiotwitter #AHAJournals ahajrnls.org/3H6YdY0
30
61
8,595
Dr. Eduardo Galvan retweeted
6 May 2025
🔍🖊️ ¿Quiere escribir un artículo de revisión?
¡Aquí encontrará los mejores tips para organizar, analizar y comunicar su trabajo con claridad y precisión! 📚✨ ¡Que su revisión sea imprescindible! 🔬
🧩sciencedirect.com/science/ar…
81
228
11,230
Dr. Eduardo Galvan retweeted
6 May 2025
🔥Just published🔥
"Catheter-based techniques for pulmonary embolism treatment" by @Costa_F_8, @MicariAntonio et al.
✅A detailed review on CDT & CDMT
✅Practical strategies for device selection, procedural planning & risk stratification
✅Insights from the PEERLESS trial
🔗 eurointervention.pcronline.c…
#InterventionalCardiology #PulmonaryEmbolism #CDMT #CDT #PEERLESS #Cardiology
18
43
3,591
Dr. Eduardo Galvan retweeted
5 May 2025
This review provides a practical outlook on catheter-directed therapies for pulmonary embolism, outlining optimal procedural planning, device selection, technical execution, evaluation of results, and management of complications. eurointervention.pcronline.c…
2
22
54
5,943